21-Jul-2011 - Drägerwerk AG & Co. KGaA

Dräger increases 2011 earnings forecast

Drägerwerk AG & Co. KGaA expects earnings in financial year 2011 to be better than previously forecasted. The Company now anticipates an EBIT margin of 8.0 percent to 9.5 percent (previously: 7.5 percent to 8.5 percent) - based on the unchanged assumption of slight net sales growth.

The reason for this improved earnings outlook is the positive business performance in the first six months of 2011. Group sales went up by about 2 percent (net of currency effects) and the EBIT margin reached around 9 percent, primarily due to the positive earnings trend in the safety division. The safety division increased net sales by roughly 9 percent (net of currency effects) and achieved an EBIT margin of approximately 12 percent in the first half of 2011 thanks to continuously strong demand in the high-margin business with industrial customers and to overall high capacity utilization. The performance of the medical division was also aided by the favorable product mix, which exceeded expectations - even though individual transactions in the previous year with above-average margins (in connection with the H1N1 virus, for instance) were not repeated and the division was unable to compensate for this. Combined with a slight drop in net sales of around 1 percent (net of currency effects) in the first six months of 2011, this lowered the EBIT margin to approximately 11 percent year-on-year.

In terms of the 2011 gross margin, Dräger expects that the positive effects from the higher proportion of business with industrial customers and the new products launched in the previous years by both divisions will offset the negative effects on margins in the medical division. Dräger still plans increases in product development investments and improvements to the Group-wide IT infrastructure. The costs for the new marketing and sales structure will not be recognized to the originally anticipated extent in 2011.

The published sales and margin estimates are based on the assumption of a steady development in the markets relevant for Dräger and unchanged exchange rates. In addition, the global situation has also become more uncertain, making an exact forecast difficult. In the medium term, the company plans to grow faster than the market and achieve a sustainable EBIT margin of at least 10 percent.

Facts, background information, dossiers
  • Dräger
More about Dräger
  • News

    Sensor technology for efficient and portable gas detection devices

    Gas sensors developed in a European project now enable the implementation of cheaper and smaller instruments with equal or higher speed and sensitivity than current laboratory-grade instruments. Production of super-sensitive and portable measuring devices is made possible by a photo-acousti ... more

    First half of 2011: Dräger continues successful trend

    Drägerwerk AG & Co. KGaA's order intake and net sales increased in the first half of 2011. Order intake after the first six months of 2011 totaled EUR 1.11 billion, 6.3 percent (net of currency effects) higher than in the previous year (6 months 2010: EUR 1.05 billion). Order intake in the ... more

    First Quarter of 2011: Dräger increases net sales and earnings

    Drägerwerk AG & Co. KGaA's order intake, net sales and earnings increased in the first quarter of 2011. Order intake went up by 11.8 percent (net of currency effects) to EUR 553.6 million year-on-year. Net sales rose by 5.7 percent (net of currency effects) to EUR 500.3 million, with partic ... more

  • Companies

    Drägerwerk AG & Co. KGaA

    Technology for Life Dräger is an international leader in the fields of medical and safety technology. The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group. The company’s long-term succes ... more